Abstract
In studies of individuals of primarily European genetic ancestry, common and low-frequency variants and rare coding variants have been found to be associated with the risk of bipolar disorder (BD) and schizophrenia (SZ). However, less is known for individuals of other genetic ancestries or the role of rare non-coding variants in BD and SZ risk. We performed whole genome sequencing of African American individuals: 1,598 with BD, 3,295 with SZ, and 2,651 unaffected controls (InPSYght study). We increased power by incorporating 14,812 jointly called psychiatrically unscreened ancestry-matched controls from the Trans-Omics for Precision Medicine (TOPMed) Program for a total of 17,463 controls. To identify variants and sets of variants associated with BD and/or SZ, we performed single-variant tests, gene-based tests for singleton protein truncating variants, and rare and low-frequency variant annotation-based tests with conservation and universal chromatin states and sliding windows. We found suggestive evidence of BD association with single-variants on chromosome 18 and of lower BD risk associated with rare and low-frequency variants on chromosome 11 in a region with multiple BD GWAS loci, using a sliding window approach. We also found that chromatin and conservation state tests can be used to detect differential calling of variants in controls sequenced at different centers and to assess the effectiveness of sequencing metric covariate adjustments. Our findings reinforce the need for continued whole genome sequencing in additional samples of African American individuals and more comprehensive functional annotation of non-coding variants.
Competing Interest Statement
A.E.L. is a shareholder of Regeneron Pharmaceuticals. K.C.B. is an employee of Oxford Nanopor Technologies Ltd. G.R.A. is a shareholder of Regeneron Pharmaceuticals.
Funding Statement
This work was supported by: University of Michigan Precision Health Scholar Award (https://precisionhealth.umich.edu/) (S.A.G.T.); R01 HG009976 (M.B.); U01MH105653 (M.B., C.N.P., S.A.M.); salary support from the Fonds de Recherche du Quebec-Sante: a Junior 1 Award and currently a Junior 2 Award (S.A.G.T.); R01 MH115676 (R.A.O.) and (DP1DA044371 and U01HG012079) (J.E.)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee, IRB Health Sciences and Behavioral Sciences (HSBS), of the University of Michigan gave ethical approval for the study. The IRB HSBS subsequently ruled the was exempt from review.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Data and Code Availability
Whole genome sequence data for the GPC samples are available in ANVIL: WGSPD Project 1: Whole Genome Sequencing for Schizophrenia and Bipolar Disorder (WGSPD1). The Anvil Terra Workspace containing the data (https://anvilproject.org/data/studies/phs002041/workspaces) is AnVIL_NIMH_Broad_WGSPD1_McCarroll_Pato_GRU_WGS. Phenotype data is available at dbGaP Study Accession: phs002041.v2.p1.
Code for ChromHMM and ConsHMM state-based analysis are available at https://github.com/ernstlab/inpsyght_states